SCHEMBL6856101

SCHEMBL6856101

CCCNCC1CNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25582070 0.83 GNAI3 (0.56)
SCHEMBL6968840 0.83 GNAI3 (0.56)
SCHEMBL29893804 0.83 GNAI3 (0.66)
SCHEMBL9437364 0.80
SCHEMBL19018618 0.80 GNAI3 (0.45)
SCHEMBL17188946 0.79 CHRNB2 (0.35)
SCHEMBL19977457 0.79 GNAI3 (0.35)
SCHEMBL5827728 0.78
SCHEMBL13772115 0.77 GNAO1 (0.70)
SCHEMBL11420212 0.77 SAT1 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353610-A1 SMALL MOLECULE MENIN INHIBITORS SERVIER PHARMACEUTICALS LLC 2021-11-18 US disclosed
WO-2017155765-A1 BICYCLIC ARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS MERCK SHARP & DOHME CORP. (US) 2017-09-14 WO disclosed
WO-2011096461-A1 QUINOLINE DERIVATIVE 大正製薬株式会社 (JP) 2011-08-11 WO disclosed